Neko Health secures $700m to expand Spotify founder’s AI clinic network to US
Spotify co-founder Daniel Ek’s Neko Health raises fresh capital from high-profile investors to scale its body-scanning operations across America.
Neko Health, the body-scanning startup founded by Spotify co-founder Daniel Ek, has secured $700 million in new funding to facilitate its expansion into the United States. The investment round, which values the company at approximately $7 billion according to sources cited by the Financial Times, will support the opening of its first US clinic in New York later this year, with further growth planned across other American cities.
The fresh capital will also be directed towards research and development of the company’s artificial intelligence-driven preventive care technology. Neko Health currently operates eight clinics across the United Kingdom and Sweden, including four in London and two in Stockholm. The company utilises custom-built medical equipment and AI to screen for conditions such as skin cancer, heart disease, and diabetes, aiming to catch health issues early before symptoms appear.
The investor group for this latest round features a mix of technology leaders and high-profile celebrities. New backers include Meta chief Mark Zuckerberg and his wife Priscilla Chan, musician will.i.am, tennis player Maria Sharapova, and former footballer Thierry Henry. Existing investors in the venture include Reddit cofounder Alexis Ohanian and actor Zoë Saldaña. This follows a previous funding round of $260 million secured in early 2025.
Neko Health was established in 2018 but remained quiet until launching publicly in 2023. The company reports that more than 350,000 individuals have joined its scan waitlists, with 100,000 people having undergone screening to date. While pricing in the UK is set at £299 and in Sweden at 2,750 Swedish kronor, the company has not yet disclosed costs for its upcoming US locations. A waitlist for the New York clinic is now active on the company’s website.
The expansion reflects a broader market shift towards private preventive care and longevity-focused health services, driven by interest in biohacking and perceived gaps in traditional reactive healthcare systems. Neko Health cofounder and CEO Hjalmar Nilsonne stated that the new funding would help take the company’s mission to the US for the first time, aiming to make disease prevention possible at scale.
